期刊文献+

抗HER2抗体修饰的聚乙二醇化壳聚糖载基因纳米粒的制备与表征 被引量:1

Preparation and Characterization of Anti-HER2-modified mPEG-Chitosan Nanoparticles
原文传递
导出
摘要 以甲氧基聚乙二醇(mPEG)接枝壳聚糖(CS)为载体制备载小干扰RNA(siRNA)的纳米粒,并用抗人表皮生长因子受体2抗体(anti-HER2)进行表面修饰。扫描电镜观察到所得纳米粒的形态为类球形,平均粒径为(160±2.4)nm,平均电位(23.5±1.7)mV,包封率为(64.2±1.6)%。体外释放试验表明,制品在初始12 h内(突释阶段)的累积释放率为14%~18%,144 h时累积释放率约70%。体外细胞试验表明,表面经anti-HER2修饰的纳米粒对SKBR-3乳腺癌细胞无明显毒性,提示其作为基因递送载体安全性较高、毒性较低。 The nanoparticles loaded with small interfering RNA (siRNA) were prepared with monomethoxy polyethylene glycol (mPEG) grafted chitosan (CS) as the carrier and then surface modified with anti-human epidermal growth factor receptor 2 antibody (anti-HER2). The observation of the scanning electron microscope showed that the product was spherical. The mean particle size, ~ potential and encapsulation efficiency of the product were (160±2.4) nm, (23.5±1.7) mV and (64.2±1.6) %, respectively. The results of in vitro release test showed that the burst release in the initial 12 h was 14% ± 18 % and the cumulative release at 144 h was about 70 %. The results of in vitro cytotoxicity test showed that the nanoparticles modified with anti-HER2 had no obvious toxicity to SKBR-3 breast cancer cells, which suggested that it might be developed as a potential gene delivery carrier with high security and low toxicity.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2012年第11期927-931,共5页 Chinese Journal of Pharmaceuticals
关键词 聚乙二醇接枝壳聚糖 小干扰RNA 抗人表皮生长因子受体2抗体 纳米粒 mPEG-chitosan small interfering RNA anti-human epidermal growth factor receptor 2 antibody nanoparticle
  • 相关文献

参考文献15

  • 1Fuchs U, Borkhardt A. The application of siRNA technology to cancer biology discovery [J]. Adv Cancer Res, 2007, 96: 75-102.
  • 2Crystal RG. Transfer of genes to humans: early lessons and obstacles to success [J]. Science, 1995, 270 (5235): 404-410.
  • 3Wolff JA, Rozema DB. Breaking the bonds: non-viral vectors become chemically dynamic [J]. Mol Ther, 2008, 16: 8-15.
  • 4Zhang C, Tang N, Liu X, et al. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene [J]. J Controlled Release, 2006, 112 (2) : 229-239.
  • 5Itaka K, Ishii T, Hasegawa Y, et al. Biodegradable polyamino acid-based polycations as safe and effective gene carrier minimizing cumulative toxicity [ J ]. Biomaterials, 2010, 31 (13) : 3707-3714.
  • 6Bhattarai N, Ramay HR, Gunn J, et al. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release [J]. J Controlled Release, 2005, 103 (3) : 609-24.
  • 7韩静绮,王丰梅,冶俊玲.乳腺癌中的ER,PR,P53,C-erbB-2和PCNA的表达及临床意义[J].第四军医大学学报,2008,29(7):663-665. 被引量:18
  • 8Kong XY, Li XY, Wang XH, et al. Synthesis and characterization of a novel MPEG-chitosan diblock copolymer and self-assembly of nanoparticles [J]. Carbohyd Polym, 2010, 79 (1) : 170-175.
  • 9Nasti A, Zaki NM, de Leonardis P, et al. Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematicoptimisation of the preparative process and preliminary biological evaluation [J]. Pharm Res, 2009, 26(8): 1918-1930.
  • 10Wu Y, Yang W, Wang C, et al. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate [J]. lnt JPharm, 2005, 295 (1-2) : 235-245.

二级参考文献5

共引文献17

同被引文献11

  • 1Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J].Nature,2001,411 (6836):494-498.
  • 2Jones SW,Souza PM,Lindsay MA.siRNA for gene silencing:a route to drug target discovery[J].Curr Opin Pharmacol,2004,4 (5):522-527.
  • 3Oh EJ,Park K,Kim KS,et al.Target specific and long-acting delivery of protein,peptide,and nucleotide therapeutics using hyaluronic acid derivatives[J].J Controlled Release,2010,141 (1):2-12.
  • 4Knudson W,Chow G,Knudson CB.CD44-Mediated uptake and degradation of hyaluronan[J].Matrix Biol,2002,21 (1):15-23.
  • 5Yang B,Zhang L,Turley EA.Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM[J].JBiol Chem,1993,268(12):8617-8623.
  • 6Chen C J,Zhao ZX,Wang JC,et al.A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid[J].Int J Nanomedicine,2012,7:3837-3849.
  • 7Jensen LB,Pavan GM,Kasimova MR,et al.Elucidating the molecular mechanism of PAMAM-siRNA dendriplex self-assembly:effect of dendrimer charge density[J].Int J Pharm,2011,416 (2):410-418.
  • 8Malik N,Wiwattanapatapee R,Klopsch R,et al.Dendrimers:relationship between structure and biocompatibility in vitro,and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo[J].J Controlled Release,2000,65 (1-2):133-148.
  • 9Quadir MA,Haag R.Biofunctional nanosystems based on dendritic polymers[J].J Controlled Release,2012,161 (2):484-495.
  • 10张维,史清洪.聚酰胺-胺型多聚物作为基因载体的研究现状[J].化学工业与工程,2009,26(2):165-168. 被引量:2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部